Literature DB >> 8825062

Regulation of intracellular cholesterol metabolism.

R Sato1, T Takano.   

Abstract

Animal cells synthesize cholesterol from acetyl CoA through a series of more than 20 enzymatic reactions. In addition, cells obtain cholesterol from plasma in the form of low-density lipoprotein (LDL), which is internalized via the LDL receptor and hydrolyzed to free cholesterol in lysosomes. Each cell must balance these internal and external sources while avoiding sterol shortage or overaccumulation. Both the biosynthetic and uptake pathways are well-regulated through feedback control. When cells are cultured in the presence of LDL, the activity of both 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase and HMG CoA reductase decline by more than 90% and the number of LDL receptors also decreases (1). In the absence of LDL, the cells maintain high activities of these two enzymes, which are rate-limiting enzymes of the biosynthetic pathway, and also maintain a large number of LDL receptors on their surface. In this review we assess recent progress in understanding the mechanisms involved in transcriptional and posttranscriptional regulation of intracellular cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825062     DOI: 10.1247/csf.20.421

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  11 in total

1.  Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.

Authors:  María P Carrasco; José M Jiménez-López; Pablo Ríos-Marco; Josefa L Segovia; Carmen Marco
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Authors:  Mari Okayasu; Mai Nakayachi; Chiyomi Hayashida; Junta Ito; Toshio Kaneda; Masaaki Masuhara; Naoto Suda; Takuya Sato; Yoshiyuki Hakeda
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

3.  HDL is redundant for adrenal steroidogenesis in LDLR knockout mice with a human-like lipoprotein profile.

Authors:  Menno Hoekstra; Miranda Van Eck
Journal:  J Lipid Res       Date:  2016-02-18       Impact factor: 5.922

4.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

5.  Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.

Authors:  José M Jiménez-López; Pablo Ríos-Marco; Carmen Marco; Josefa L Segovia; María P Carrasco
Journal:  Lipids Health Dis       Date:  2010-03-25       Impact factor: 3.876

6.  c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate.

Authors:  Lia R Edmunds; Lokendra Sharma; Audry Kang; Jie Lu; Jerry Vockley; Shrabani Basu; Radha Uppala; Eric S Goetzman; Megan E Beck; Donald Scott; Edward V Prochownik
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

7.  Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums.

Authors:  Jeannie Chan; Lisa M Donalson; Rampratap S Kushwaha; Sacha Ferdinandusse; Jane F VandeBerg; John L VandeBerg
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

8.  Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat.

Authors:  Jeannie Chan; Francis E Sharkey; Rampratap S Kushwaha; Jane F VandeBerg; John L VandeBerg
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-03       Impact factor: 4.871

9.  Molecular processes during fat cell development revealed by gene expression profiling and functional annotation.

Authors:  Hubert Hackl; Thomas Rainer Burkard; Alexander Sturn; Renee Rubio; Alexander Schleiffer; Sun Tian; John Quackenbush; Frank Eisenhaber; Zlatko Trajanoski
Journal:  Genome Biol       Date:  2005-12-19       Impact factor: 13.583

10.  Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.

Authors:  Hardik Ghelani; Valentina Razmovski-Naumovski; Vamsi Inampudi; Dennis Chang; Srinivas Nammi
Journal:  Biomed Res Int       Date:  2019-11-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.